| Dr Samantha Renee Andreaggi, OD | |
|
920 Providence Rd Ste 100, Towson, MD 21286-2976 | |
| (443) 394-8679 | |
| Not Available |
| Full Name | Dr Samantha Renee Andreaggi |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 11 Years |
| Location | 920 Providence Rd Ste 100, Towson, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013357532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA 2355 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Care Associates Of Maryland Llc | 1850491994 | 19 |
News Archive
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
News outlets are reporting that some states and businesses who oppose parts or all of the health reform law are applying for the financial relief it provides.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
› Verified 7 days ago
| Provider Name | Levin Eye Care Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437295300 PECOS PAC ID: 8527160431 Enrollment ID: O20070223000417 |
News Archive
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
News outlets are reporting that some states and businesses who oppose parts or all of the health reform law are applying for the financial relief it provides.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
› Verified 7 days ago
| Provider Name | Eye Care Associates Of Maryland Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1588784235 PECOS PAC ID: 1850491994 Enrollment ID: O20070703000127 |
News Archive
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
News outlets are reporting that some states and businesses who oppose parts or all of the health reform law are applying for the financial relief it provides.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samantha Renee Andreaggi, OD 920 Providence Rd, Ste 100, Towson, MD 21286-2976 Ph: (410) 486-1010 | Dr Samantha Renee Andreaggi, OD 920 Providence Rd Ste 100, Towson, MD 21286-2976 Ph: (443) 394-8679 |
News Archive
A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
News outlets are reporting that some states and businesses who oppose parts or all of the health reform law are applying for the financial relief it provides.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.
› Verified 7 days ago
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 825 Dulaney Valley Rd, Space 2135, Towson, MD 21204 Phone: 410-296-0289 | |
Valerie Witaker, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 825 Dulaney Valley Rd, Suite 1335, Towson, MD 21204 Phone: 301-590-9191 Fax: 301-590-3971 | |
Lizanette Paulino, OD Optometrist Medicare: Medicare Enrolled Practice Location: 825 Dulaney Valley Rd Ste 1335, Towson, MD 21204 Phone: 410-823-3830 | |
Martin J Mcginn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8625 Pleasant Plains Rd, Towson, MD 21286 Phone: 410-828-5558 Fax: 410-823-6315 | |
Dr. Robert Scott Stutman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 8601 Lasalle Rd, Suite 108, Towson, MD 21286 Phone: 410-821-6400 Fax: 410-296-4722 | |
Ruxton Towers Eye Associates Optometrist Medicare: Medicare Enrolled Practice Location: 8415 Bellona Lane, Suite 104, Towson, MD 21204 Phone: 410-828-9270 Fax: 410-321-0124 |